Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Champions Oncology (CSBR) Other Gross PP&E Adjustments (2016 - 2026)

Champions Oncology has reported Other Gross PP&E Adjustments over the past 15 years, most recently at $12.2 million for Q1 2026.

  • For Q1 2026, Other Gross PP&E Adjustments rose 7.51% year-over-year to $12.2 million; the TTM value through Jan 2026 reached $12.2 million, up 7.51%, while the annual FY2025 figure was $9.8 million, 61.03% up from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 was $12.2 million at Champions Oncology, up from $12.0 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $12.2 million in Q1 2026 and troughed at $607000.0 in Q2 2022.
  • A 5-year average of $8.3 million and a median of $9.6 million in 2023 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: decreased 6.08% in 2022 and later surged 637.07% in 2023.
  • Year by year, Other Gross PP&E Adjustments stood at $6.7 million in 2022, then soared by 44.15% to $9.6 million in 2023, then increased by 9.51% to $10.5 million in 2024, then grew by 13.71% to $12.0 million in 2025, then rose by 1.44% to $12.2 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for CSBR at $12.2 million in Q1 2026, $12.0 million in Q4 2025, and $11.5 million in Q3 2025.